Optic neuropathy associated with the use of over-the-counter sexual enhancement supplements

Sapir Z. Karli, Sophie D. Liao, Andrew R. Carey, Byron L Lam, Sara Wester

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

This case report details an association of the use of over-the-counter sexual enhancement supplements with atypical optic neuropathy. A 42-year-old man presented with right-sided headache and vision loss of the right eye, which deteriorated to a single quadrant of hand motion over 11 days. Serial orbital magnetic resonance imaging scans demonstrated progressive orbital optic nerve enhancement extending into the optic canal despite high-dose steroid treatment. The patient eventually admitted to using several over-the-counter sexual enhancement supplements prior to the onset of symptoms and throughout the course of his steroid treatment, which he subsequently discontinued. His vision improved to 20/200 with an expanded visual feld. Anterior ischemic optic neuropathy has been reported in association with phosphodiesterase (PDE)-5 inhibitor use, but visual loss in association with unregulated sexual enhancement supplements has not been studied. While one case cannot establish association, our case is suggestive of potential dangers of over-the-counter sexual enhancement supplements, which may contain PDE-5 inhibitors, “male hormones,” and “substances that enhance blood production.” The case also underscores the importance of obtaining a careful history of supplements in patients with optic neuropathies.

Original languageEnglish
Pages (from-to)2171-2175
Number of pages5
JournalClinical Ophthalmology
Volume8
DOIs
StatePublished - Oct 29 2014

    Fingerprint

Keywords

  • Optic neuropathy
  • PDE-5 inhibitor
  • Sildenafl

ASJC Scopus subject areas

  • Ophthalmology

Cite this